Elsevier

The Lancet

Volume 343, Issue 8907, 14 May 1994, Pages 1209-1211
The Lancet

Clinical practice
Completeness of reporting trial results: effect on physicians' willingness to prescribe

https://doi.org/10.1016/S0140-6736(94)92407-4Get rights and content

Abstract

Clinical trials may lead to conflicting results. We studied how different ways of reporting results affected physicians' recommendations. A questionnaire distributed to 148 general practitioners presented results of a clinical trial where a reduction of cardiac events and an increase of mortality was reported. Results were shown in four different ways—relative risk reduction, absolute risk reduction, percentages of event-free patients, number needing to be treated to prevent an event—as if they derived from different trials. A fifth presentation was the reduced rate of cardiac events along with the increased rate of mortality. Physicians were asked to estimate how much they would be willing to prescribe each drug. The mean agreement of physicians' decisions was 77 (28)% for relative risk reduction, 24 (28)% for absolute risk reduction, 37 (37)% for different percentages event-free patients, 34 (34)% for number need to treat, and 23 (28)% for events reduction and mortality for increase (p<0·001 relative risk vs others). The method of reporting trial results and the completeness of information in the case of controversial results affects physicians willingness to prescribe.

References (31)

  • C. Vergani

    Prevenzione della malattia coronarica: l'importanza della terapia continuativa normolipemizzante

    JAMA (Italian Edition)

    (1991)
  • A. Lupacis et al.

    An assessment of clinically useful measures of the consequences of treatment

    N Engl J Med

    (1988)
  • Jh Comroe

    The road from research to new diagnosis and therapy

    Science

    (1978)
  • Tg Pickering

    Treatment of mild hypertension and the reduction of cardiovascular mortality: the 'of' or 'by' dilemma

    JAMA

    (1983)
  • As Brett

    Treating hypercholesterolemia. How should practising physicians interpret the published data for patients?

    N Engl J Med

    (1989)
  • Cited by (180)

    • Rosacea: Relative risk versus absolute risk of malignant comorbidities

      2019, Journal of the American Academy of Dermatology
    • Large Clinical Trials and Registries-Clinical Research Institutes

      2018, Principles and Practice of Clinical Research
    • Comorbidities in patients with psoriasis: The role of the dermatologist

      2017, Journal of the American Academy of Dermatology
    View all citing articles on Scopus
    View full text